Guest guest Posted December 11, 2003 Report Share Posted December 11, 2003 http://www.avemar.net/onkologia_engl.html IMMUNOLOGYCAL RESEARCH One of Avemar’s most interesting properties from the perspective of research is its immunoregulating capability. In malignancies it stimulates the immune system. In autoimmune diseases it is immunosuppressive. Avemar is able to act seemingly in opposite directions, because it has different effects on the two main parts of the immune response. It increases type TH1 immune response, therefore activates immune mechanisms against cancer, at the same time slows type TH2 immune response, so inhibits autoimmune processes. In animal studies Avemar inhibited the development of SLE, significantly decreased the clinical and hematological symptoms of the disease. In clinical trials Avemar significantly improved the condition of patients with rheumatoid arthritis. In animal studies Avemar had a strongly significant, dose-dependent anti-inflammatory effect. -------------------------------------------------------------------- mail2web - Check your email from the web at http://mail2web.com/ . Quote Link to comment Share on other sites More sharing options...
Guest guest Posted December 12, 2003 Report Share Posted December 12, 2003 And so we go round in circles. I went to the site, and this nutrient's main ingredient is wheat gluten, which is, one will recall, a big no-no on the Best Bet diet. I wonder if there will ever be any agreement anywhere about MS, apart from " It sucks. " Galoux, especially sick of MS today Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 13, 2006 Report Share Posted June 13, 2006 Dr. also recommended AHCC. Which is better and more cost effective? Please advise. Jim Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.